Acadia Pharmaceuticals Inc

General

Total Cases9

Active Cases2

Patents90

CourtsD. Delaware

TypeOperating Company

Elite Ratings

--

acadia-pharm.com

acadia-pharmaceuticals

acadia-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
01/13/25	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	[SEALED] Proposed Findings of Fact by ACADIA Pharmaceuticals Inc.. (Attachments: # [1] Certificate of Service)(Streifthau-Livizos, Michelle) (Entered: 01/13/2025)
01/13/25	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	[SEALED] POST TRIAL BRIEF by ACADIA Pharmaceuticals Inc.. (Attachments: # [1] Certificate of Service)(Streifthau-Livizos, Michelle) (Entered: 01/13/2025)
01/13/25	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	OPENING BRIEF in Support Post Trial Briefing filed by MSN Laboratories Private Ltd..Answering Brief/Response due date per Local Rules is 1/27/2025. (Attachments: # [1] Findings Of Fact)(Green, James) (Entered: 01/13/2025)
12/20/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	REDACTED VERSION of [112] Memorandum Opinion by ACADIA Pharmaceuticals Inc.. (Guzzo, Jennifer) (Entered: 12/20/2024)
12/18/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	ORAL ORDER: Having reviewed the parties' joint letter, D.I. 122, and the proposed public redacted form of the Memorandum Opinion sealed at D.I. 112, the parties may file the public redacted version of D.I. 112 with the redactions proposed in D.I. 123 on or before December 20, 2024. D.I. 113 shall be unsealed in its entirety. ORDERED by Judge Gregory B. Williams on 12/18/2024. (lnb) (Entered: 12/18/2024) ORAL ORDER: Having reviewed the parties' joint letter, D.I. 122, and the proposed public redacted form of the Memorandum Opinion sealed at D.I. 112, the parties may file the public redacted version of D.I. 112 with the redactions proposed in D.I. 123 on or before December 20, 2024. D.I. 113 shall be unsealed in its entirety. ORDERED by Judge Gregory B. Williams on 12/18/2024. (lnb) (Entered: 12/18/2024)
12/16/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	[SEALED] REDACTED VERSION of [112] Memorandum Opinion Proposed Redactions by ACADIA Pharmaceuticals Inc.. (Guzzo, Jennifer) (Entered: 12/16/2024)
12/16/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	Letter to The Honorable Gregory B. Williams from Jennifer Becnel-Guzzo regarding proposed redacted form of the Memorandum Opinion related to the Motions in Limine - re [113] Order, [112] Memorandum Opinion. (Guzzo, Jennifer) (Entered: 12/16/2024)
12/13/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	SO ORDERED, re [121] Stipulation Amending Supplemental Scheduling Order. Signed by Judge Gregory B. Williams on 12/13/2024. (lnb) (Entered: 12/13/2024)
12/12/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	Letter to The Honorable Gregory B. Williams from James S. Green, Jr., Esquire regarding Joint Request Of All Parties To Amend Supplemental Scheduling Order On Post-Trial Submission Deadlines. (Attachments: # [1] Stipulation And Proposed Order amending Supplemental Scheduling Order)(Green, James) (Entered: 12/12/2024)
12/09/24	Acadia Pharmaceuticals Inc v. Aurobindo Pharma Ltd 1:22-CV-01387 ( D. DE )	SUPPLEMENTAL SCHEDULING ORDER. Signed by Judge Gregory B. Williams on 12/9/2024. (lnb) (Entered: 12/09/2024)